Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,834 | N/A | N/A | N/A | 0 |
| Other current assets | 0 | 0 | 0 | 0 | 120 |
| TOTAL | $22,428 | $N/A | $N/A | $N/A | $120 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $22,428 | $N/A | $N/A | $N/A | $120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 459 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 819 | N/A | N/A | N/A | 280 |
| TOTAL | $1,278 | $N/A | $N/A | $N/A | $280 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,183 | 0 | 0 | 0 | 0 |
| TOTAL | $27,183 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $28,461 | $N/A | $N/A | $N/A | $280 |
| Shareholders' Equity | |||||
| Common Shares | 1 | N/A | N/A | N/A | 1 |
| Retained earnings | -9,298 | N/A | N/A | N/A | -160 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $-6,033 | $N/A | $N/A | $N/A | $-160 |
| Total Liabilities And Equity | $22,428 | $0 | $0 | $0 | $120 |